MG
ORTX

Michael Gelband’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Michael Gelband’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,601
Closed -$116K – 2939
2021
Q1 		$116K Buy
+1,601
New +$114K ﹤0.01% 1962

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Michael Gelband's ORTX Position: Q2 2021 in Review

Michael Gelband sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2021, closing a stake of 1,601 shares — an estimated $116K sold.

Michael Gelband first reported a position in ORTX in Q1 2021 and held it in 1 quarter. The position peaked at $116K in Q1 2021. 85 funds tracked by Wall St. Rank hold ORTX as of Q2 2021.

  • Michael Gelband reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Michael Gelband sold 1,601 Orchard Therapeutics plc American Depositary Shares shares in Q2 2021, an estimated $116K.
  • Michael Gelband first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Michael Gelband's Orchard Therapeutics plc American Depositary Shares position peaked at $116K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.